The latest closing stock price for Travere Therapeutics as of September 18, 2024 is 14.35.
An investor who bought $1,000 worth of Travere Therapeutics stock at the IPO in 2012 would have $8,567 today, roughly 9 times their original investment - a 20.71% compound annual growth rate over 12 years.
The all-time high Travere Therapeutics stock closing price was 36.10 on August 05, 2015.
The Travere Therapeutics 52-week high stock price is 14.79, which is 3.1% above the current share price.
The Travere Therapeutics 52-week low stock price is 5.12, which is 64.3% below the current share price.
The average Travere Therapeutics stock price for the last 52 weeks is 8.03.
An investor who bought $1,000 worth of Travere Therapeutics stock at the IPO in 2012 would have $8,567 today, roughly 9 times their original investment - a 20.71% compound annual growth rate over 12 years.
The all-time high Travere Therapeutics stock closing price was 36.10 on August 05, 2015.
The Travere Therapeutics 52-week high stock price is 14.79, which is 3.1% above the current share price.
The Travere Therapeutics 52-week low stock price is 5.12, which is 64.3% below the current share price.
The average Travere Therapeutics stock price for the last 52 weeks is 8.03.